Vericel (VCEL) EBIT Margin (2011 - 2026)

Vericel (VCEL) reported EBIT Margin of 11.79% for Q1 2026, up 1254.0% on a YoY basis from 0.87% in Q1 2025, and down 148.85% sequentially from 24.12% in Q4 2025.

Vericel (VCEL) EBIT Margin (2011 - 2026) Analysis & Trends

Vericel (VCEL) has 16 years of EBIT Margin data on file, last reported at 11.79% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin rose 1254.0% year-over-year to 11.79%; the trailing twelve-month figure through Mar 2026 stood at 5.4% (up 658.0% YoY), and the FY2025 full-year result was 4.0%, up 209.0% from the prior year.
  • EBIT Margin eased to 11.79% in Q1 2026, from 24.12% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 24.52% in Q4 2024 to a low of 24.66% in Q2 2022.
  • A 5-year average of 5.14% and a median of 11.09% in 2023 frame the typical range for EBIT Margin.
  • Across the five-year window, EBIT Margin plunged 1523 bps in 2022 and jumped 1254 bps in 2026, its largest moves.
  • Tracing VCEL's EBIT Margin over 5 years: stood at 11.55% in 2022, then surged by 70 bps to 19.59% in 2023, then gained by 25 bps to 24.52% in 2024, then fell by 2 bps to 24.12% in 2025, then tumbled by 149 bps to 11.79% in 2026.
  • Business Quant data shows VCEL's EBIT Margin at 11.79% in Q1 2026, 24.12% in Q4 2025, and 5.11% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn -11.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.79%
Dec 31, 2025 24.12%
Sep 30, 2025 5.11%
Jun 30, 2025 -3.21%
Mar 31, 2025 -24.32%
Dec 31, 2024 24.52%
Sep 30, 2024 -4.26%
Jun 30, 2024 -11.45%
Mar 31, 2024 -10.66%
Dec 31, 2023 19.59%
Sep 30, 2023 -11.09%
Jun 30, 2023 -12.98%
Mar 31, 2023 -19.94%
Dec 31, 2022 11.55%
Sep 30, 2022 -17.71%
Jun 30, 2022 -24.66%
Mar 31, 2022 -20.29%
Dec 31, 2021 8.70%
Sep 30, 2021 -14.71%
Jun 30, 2021 -9.44%